Symbol="BCYC"
AssetType="Common Stock"
Name="Bicycle Therapeutics Ltd"
Description="Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, is developing a class of drugs for diseases that are not served by existing treatments. The company is headquartered in Cambridge, the United Kingdom."
CIK="1761612"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="B900 BABRAHAM RESEARCH CAMPUS, CAMBRIDGE, GB"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="774571000"
EBITDA="-141032000"
PERatio="None"
PEGRatio="None"
BookValue="7.2"
DividendPerShare="0"
DividendYield="0"
EPS="-4.06"
RevenuePerShareTTM="0.753"
ProfitMargin="0"
OperatingMarginTTM="-6.52"
ReturnOnAssetsTTM="-0.204"
ReturnOnEquityTTM="-0.527"
RevenueTTM="22518000"
GrossProfitTTM="-67146000"
DilutedEPSTTM="-4.06"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.603"
AnalystTargetPrice="48.92"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="61.69"
PriceToBookRatio="3.139"
EVToRevenue="39.3"
EVToEBITDA="-6.12"
Beta="0.72"
num_52WeekHigh="33.49"
num_52WeekLow="18.84"
num_50DayMovingAverage="24.69"
num_200DayMovingAverage="25.1"
SharesOutstanding="36161100"
DividendDate="None"
ExDividendDate="None"
symbol="BCYC"
open="21.29"
high="22.44"
low="20.37"
price="22.10"
volume="255371.00"
latest_trading_day="2023-08-18"
previous_close="21.42"
change="0.68"
change_percent="3.1746%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="48"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="52"
Volume_recent_avg="251831"
Change_recent_avg="-0.01"
Delta_recent_avg="1.34"
Variance_recent_avg="0.67"
Change_ratio_recent_avg="-0.1"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="52"
Aroon_momentum_negative="48"
image_negative_thumbnail_id_1="1087"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0120.jpeg"
image_negative_thumbnail_id_2="156"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0020.jpeg"
image_neutral_thumbnail_id_1="566"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_neutral_thumbnail_id_2="579"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0020.jpeg"
image_positive_thumbnail_id_1="960"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0122.jpeg"
image_positive_thumbnail_id_2="664"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0044.jpeg"
image_professor_thumbnail_id_1="1187"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
